Results 211 to 220 of about 22,992 (284)

Ginsenoside Rg1 as a Multifunctional Therapeutic Agent: Pharmacological Properties, Molecular Mechanisms and Clinical Perspectives in Complementary Medicine

open access: yesFood Science &Nutrition, Volume 14, Issue 2, February 2026.
Ginsenoside Rg1 (Rg1) from Panax ginseng shows multifunctional health effects. Although oral bioavailability is low and blood–brain barrier (BBB) penetration is limited, delivery systems such as liposomes and nanoparticles may improve exposure. Rg1 reduces inflammation/oxidative stress by inhibiting nuclear factor‐κB (NF‐κB) signaling and reactive ...
Hernán Cortés   +13 more
wiley   +1 more source

Novel Echocardiographic Index for Risk Stratification of Ventricular Arrhythmias and Mortality Based on Right Ventricular Function

open access: yesJournal of Arrhythmia, Volume 42, Issue 1, February 2026.
Patients undergoing ICD implantation with both preprocedural echocardiography and cardiac magnetic resonance (CMR) were retrospectively analyzed to assess right ventricular (RV) function. Echocardiographic RV fractional area change (RVFAC) and the contraction pressure index (CPI), as well as CMR‐derived RV ejection fraction (RVEF), predicted ...
Toshinori Chiba   +11 more
wiley   +1 more source

A Case of VF Misclassification Corrected by VF Therapy Assurance: Implications for ICD Programming

open access: yesJournal of Arrhythmia, Volume 42, Issue 1, February 2026.
Implantable cardioverter‐defibrillator undersensing may delay therapy in ventricular fibrillation with low‐amplitude signals. Ventricular fibrillation therapy assurance (VFTA) detected persistent VF after initial shock failure, enabling timely shock delivery and successful resuscitation.
Naoki Matsumoto   +4 more
wiley   +1 more source

A Rare Case of RNRVAS Termination and Re‐Initiation Visualized on a 12‐Lead ECG

open access: yesJournal of Arrhythmia, Volume 42, Issue 1, February 2026.
This case illustrates both termination and re‐initiation of repetitive non‐reentrant ventriculoatrial synchrony (RNRVAS) visualized on a standard 12‐lead ECG. It highlights how pacemaker algorithms such as VIP and PVC response, together with abnormal atrial refractoriness, can trigger or terminate RNRVAS.
Tomoyoshi Morioku   +4 more
wiley   +1 more source

Wild Type Transthyretin Amyloid Cardiomyopathy Hidden Under Ablation‐Refractory Atrial Arrhythmias and the Potential Contribution of Tafamidis in Rhythm Control

open access: yesJournal of Arrhythmia, Volume 42, Issue 1, February 2026.
An octogenarian man with a history of multiple catheter ablation failures for atrial fibrillation and tachycardia was diagnosed with transthyretin amyloid cardiomyopathy. After 1 year of tafamidis therapy, the patient experienced spontaneous restoration of sinus rhythm, and follow‐up image of 99mTc‐pyrophosphate scintigraphy revealed a marked decrease ...
Tomoki Horie   +4 more
wiley   +1 more source

Clinical outcomes after ventricular tachycardia ablation with or without induction. [PDF]

open access: yesHeart Rhythm O2
Freedman BL   +5 more
europepmc   +1 more source

Ablation of Ventricular Tachycardia Using the QDOT MICRO Ablation Catheter (VT‐MICRO Study)

open access: yesJournal of Arrhythmia, Volume 42, Issue 1, February 2026.
Catheter ablation is useful to treat patients with ventricular tachycardia. QDOT Micro catheter is a next generation catheter designed to provide more efficient lesion creation with an accurate myocardial substrate analysis. Microelectrode mapping allows detection of higher voltage electrograms compared to standard bipolar mapping and Pentaray mapping.
Antonio Di Monaco   +6 more
wiley   +1 more source

Preprocedural imaging guiding ventricular tachycardia ablation in structural heart disease. [PDF]

open access: yesJ Arrhythm
Nunes-Ferreira A   +5 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy